Clinical Trial: PD-1 Inhibitors Combined With Targeted Therapy With or Without Interventional Therapy for Advanced HCC

U.S., Sept. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07157969) titled 'PD-1 Inhibitors Combined With Targeted Therapy With or Without Interventional Therapy for Advanced HCC' on Aug. 28.

Brief Summary: This trial is designed to explore the efficacy and safety of interventional therapy combined with PD-1 inhibitors and targeted therapy in the treatment of advanced hepatocellular carcinoma. Eligible participants will be divided into two groups based on their treatment plans: one receiving PD-1 inhibitors combined with targeted therapy, and the other receiving PD-1 inhibitors combined with targeted therapy alongside interventional therapy, which includes C-TACE, D-TACE, and HAIC. The specific number and i...